Clinical Trial Update: TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating trastuzumab with radiotherapy to prevent brain metastases in breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Breast Cancer, Metastasis | Phase 3 | Status: TERMINATED